Target Price | CHF27.00 |
Price | CHF17.36 |
Potential |
55.53%
register free of charge
|
Number of Estimates | 1 |
1 Analyst has issued a Kuros Biosciences price target 2026.
The average Kuros Biosciences target price is CHF27.00.
This is
55.53%
register free of charge
|
|
A rating was issued by 1 analysts: 1 Analysts recommend Kuros Biosciences to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Kuros Biosciences stock has an average upside potential 2026 of
55.53%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million CHF | 75.56 | 124.00 |
125.15% | 64.11% | |
EBITDA Margin | 3.40% | 12.74% |
144.24% | 274.57% |
1 Analyst has issued a sales forecast Kuros Biosciences 2025 . The average Kuros Biosciences sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued an EBITDA forecast Kuros Biosciences 2025 . The average Kuros Biosciences EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
EV/Sales | 5.21 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.